MedPath

The effect of NBS powder in treatment of patients with multi-drug resistant tuberculosis

Phase 3
Conditions
Respiratory tuberculosis.
Respiratory tuberculosis
Registration Number
IRCT20230116057135N1
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
88
Inclusion Criteria

Patients with multi-drug resistant tuberculosis
Patients over 18 years old

Exclusion Criteria

The patient's withdrawal from the study
Patients with any other chronic disease such as diabetes, cardiovascular disease, etc.
Patients who have received supplements of vitamin D, zinc, B vitamins and other micronutrients in the last month.
Patients who do not come for follow-up treatment at specified intervals
Pregnant and lactating mothers
Use of corticosteroids and immunosuppressive drugs
Observing any drug sensitivity (especially digestive sensitivity to gluten) as determined by the attending physician
Deterioration of the patient's clinical symptoms due to the consumption of Nutrition Bio-Shield (NBS) powder, as determined by the attending physician
Patient's death during common and selective treatments (in case of death, the patient's information is fully recorded and laboratory tests are performed along with other samples to determine the possible effect of the drug on the patient's death)

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Microbial load. Timepoint: Before of the intervention, monthly monitoring, after of the intervention. Method of measurement: Examining the Ziehl–Neelsen staining slide, colony count.;Measurement of white blood cells. Timepoint: Before of the intervention, After of the intervention. Method of measurement: Cell Counter.;Measurement of inflammatory factors. Timepoint: Before of the intervention, After of the intervention. Method of measurement: Gold Standard Methods (Westergren method for ESR, Electrochemical Immunoassay for CRP).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath